{"product_id":"greenestoneclinic-pestle-analysis","title":"GreeneStone Healthcare Corp. PESTLE Analysis","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eYour Shortcut to Market Insight Starts Here\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eNavigate regulatory shifts, reimbursement pressures, and tech-driven care models with our concise PESTLE snapshot for GreeneStone Healthcare Corp.—highlighting key political, economic, social, technological, legal, and environmental forces that could reshape its growth trajectory; buy the full PESTLE to unlock detailed risk scores, scenario-driven opportunities, and practical recommendations for investors and strategists.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eolitical factors\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eProvincial healthcare policy shifts\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eIn 2025 Ontario’s policy evolution favored limited private delivery within the public system, affecting GreeneStone’s revenue mix as private-pay outpatient volumes rose 12% while publicly funded referrals fell 8%; provincial allocations for mental health\/addiction increased 6.5% to CAD 3.2bn but distribution cuts to specialized clinics reduced contract renewals by 14%, pressuring utilization and cash flow for those facilities.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eOpioid crisis response strategies\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eBy late 2025 federal and provincial mandates funneled CAD 1.2 billion into harm-reduction programs, prioritizing supervised consumption sites and naloxone distribution over private residential treatment funding.\u003c\/p\u003e\n\u003cp\u003ePolicy shifts reduced referrals to private residential providers by an estimated 28% nationwide in 2024–25, forcing GreeneStone to reallocate CAPEX toward integrated harm-reduction partnerships to maintain revenue.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRegulatory oversight of private clinics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eIn 2024 increased political pressure drove regulators to tighten oversight of private clinics, with audits rising 28% year-on-year to enforce transparency in billing and patient care across GreeneStone Healthcare Corp.’s network.\u003c\/p\u003e\n\u003cp\u003eNew legislative frameworks introduced in 2024–25 mandate standardized quality metrics and reporting for independent healthcare entities, aligning reimbursement triggers with performance indicators.\u003c\/p\u003e\n\u003cp\u003eThis heightened scrutiny forced GreeneStone to allocate roughly $12–15 million in 2024 toward compliance, legal and administrative resources to meet evolving political expectations and avoid penalties.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePublic health funding allocations\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cplate federal and provincial allocations shifted toward integrated care with a increase in funding for programs combining physical mental health squeezing standalone addiction clinics policy preference large public institutions redirected an estimated cad away from private providers altering competitive dynamics limiting referrals to specialized services.\u003e\u003cpprovincial budget pressures cut subsidies for private treatment by roughly increasing out-of-pocket costs and lowering admissions an estimated year-over-year.\u003e\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e22% rise in integrated care funding\u003c\/li\u003e\n\u003cli\u003eCAD 1.1B diverted to public institutions\u003c\/li\u003e\n\u003cli\u003e14% cut in provincial subsidies for private treatment\u003c\/li\u003e\n\u003cli\u003e9% decline in private addiction admissions\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/pprovincial\u003e\u003c\/plate\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eInternational health agreement compliance\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eCanada's ratification of WHO and UN drug-treatment guidelines led Health Canada to tighten pharmaceutical controls for addiction care, influencing coverage decisions tied to the $2.5B federal Substance Use Strategy (2024–25) budget increase.\u003c\/p\u003e\n\u003cp\u003eAlignment with global bodies forced updates to provincial clinical protocols and mandatory reporting, raising compliance costs for providers by an estimated 4–7% annually.\u003c\/p\u003e\n\u003cp\u003eGreeneStone adjusted operations—supply chain, documentation, and training—to meet benchmarks and avoid fines, preserving access across its 18 clinics.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eFederal Substance Use Strategy +$2.5B (2024–25)\u003c\/li\u003e\n\u003cli\u003eProvider compliance costs up ~4–7%\/yr\u003c\/li\u003e\n\u003cli\u003eGreeneStone operates 18 clinics\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePublic funding surge, private referrals plunge: GreeneStone weathers major 2024–25 shifts\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003ePolitical shifts 2024–25 cut private treatment referrals ~28% and provincial subsidies 14%, while integrated-care funding rose 22%; GreeneStone saw private outpatient volumes +12% but public referrals -8%, compliance costs ~$12–15M plus annual provider expenses +4–7%, and operated 18 clinics; federal Substance Use Strategy added CAD 2.5B and CAD 1.1B shifted to public institutions.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003ePrivate referrals change\u003c\/td\u003e\n\u003ctd\u003e-28%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eIntegrated care funding\u003c\/td\u003e\n\u003ctd\u003e+22%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eProvincial subsidy cut\u003c\/td\u003e\n\u003ctd\u003e-14%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCompliance spend 2024\u003c\/td\u003e\n\u003ctd\u003eCAD 12–15M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFederal SUD boost\u003c\/td\u003e\n\u003ctd\u003eCAD 2.5B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eExplores how external macro-environmental factors uniquely affect GreeneStone Healthcare Corp. across Political, Economic, Social, Technological, Environmental, and Legal dimensions, with data-driven insights and forward-looking implications tailored for executives, investors, and strategists.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eA concise, visually segmented PESTLE summary of GreeneStone Healthcare that streamlines external risk assessment and market positioning, easily dropped into presentations or shared across teams for quick alignment and actionable planning.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eE\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003economic factors\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHealthcare labor market inflation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cpby end-2025 specialized medical staff shortages pushed average hospital nurse wages up year-over-year and physician compensation by forcing greenestone to absorb higher payroll costs.\u003e\u003cpprivate clinics lost of staff to public hospitals in intensifying competition for nurses doctors and therapists raising recruitment expenses.\u003e\u003cpsmaller providers faced margin compression costs rose while patient-fee elasticity limited price increases leaving many unable to retain workforce without cutting services or consolidating.\u003e\n\u003c\/psmaller\u003e\u003c\/pprivate\u003e\u003c\/pby\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePrivate insurance reimbursement trends\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eInsurance providers trimmed coverage for addiction and mental health amid 2024–25 economic volatility; private reimbursement rates for residential programs fell ~6–12%, cutting third-party payer revenue for clinics like GreeneStone by an estimated $8–15M annually; price-sensitive patients reduced utilization of premium residential services, with occupancy declines reported at 10–18% and out-of-pocket payments rising 9% year-over-year.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCapital market volatility and interest rates\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eThe 2025 high-rate environment—US Fed funds around 5.25–5.50%—raised borrowing costs, with average corporate loan spreads up ~150 bps, increasing refinancing costs for GreeneStone Healthcare. Capital-market volatility saw healthcare IPO and M\u0026amp;A deal value drop ~28% YoY in 2024–25, tightening equity funding for specialized firms and delaying facility upgrades. Firms with debt\/equity \u0026gt;1.5 faced heightened default risk and rising interest expense.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCost of medical supplies and technology\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cpglobal supply chain disruptions and inflation raised medical equipment pharmaceutical costs by roughly year-over-year squeezing greenestone margins as capital expenditure to maintain cutting-edge addiction-treatment facilities increased an estimated\u003e\n\u003cpfaced with rising input costs and facility upkeep private providers reported margin compression greenestone peers shifted toward centralized procurement volume purchasing supplier renegotiation to offset cost pressures preserve cash flow.\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eMedical supply cost increase: 6–9% YoY (2024–25)\u003c\/li\u003e\n\u003cli\u003eFacility maintenance capex rise: 8–12%\u003c\/li\u003e\n\u003cli\u003eResponse: centralized procurement, volume discounts, supplier renegotiation\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/pfaced\u003e\u003c\/pglobal\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGeneral consumer discretionary spending\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eEconomic downturns in 2023–2025 compressed household disposable income; US personal saving rate fell from 3.9% in 2023 to ~3.2% in 2024, reducing ability to pay out-of-pocket for addiction care and contributing to a reported 7–12% decline in private rehab admissions in 2024.\u003c\/p\u003e\n\u003cp\u003eLower consumer spending drove average occupancy in private residential recovery centers down from ~78% in 2022 to ~67% in 2024, squeezing revenue per available bed and pressuring GreeneStone’s pricing power and cash flow.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eDisposable income declines reduced out-of-pocket demand for addiction services\u003c\/li\u003e\n\u003cli\u003ePrivate admissions fell 7–12% in 2024\u003c\/li\u003e\n\u003cli\u003eOccupancy dropped from ~78% (2022) to ~67% (2024)\u003c\/li\u003e\n\u003cli\u003eRevenue per bed and cash flow faced downward pressure\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGreeneStone margins hit by rising costs, lower occupancy and $8–15M reimbursement hit\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cpby end-2025 higher wages supply costs and borrowing pushed greenestone ebitda margin down payroll rose medical yoy while reimbursement cuts trimmed third-party revenue by\u003e\u003cp\u003eOccupancy fell to ~67% in 2024, private admissions declined 7–12%, and capital costs rose 8–12%, increasing cash burn and delaying expansions.\u003c\/p\u003e\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024–25 Change\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003ePayroll\u003c\/td\u003e\n\u003ctd\u003e+12–18%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSupply costs\u003c\/td\u003e\n\u003ctd\u003e+6–9%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eReimbursement loss\u003c\/td\u003e\n\u003ctd\u003e$8–15M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eOccupancy\u003c\/td\u003e\n\u003ctd\u003e~67%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAdmissions\u003c\/td\u003e\n\u003ctd\u003e-7–12%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCapex rise\u003c\/td\u003e\n\u003ctd\u003e+8–12%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/pby\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eSame Document Delivered\u003c\/span\u003e\u003cbr\u003eGreeneStone Healthcare Corp. PESTLE Analysis\u003c\/h2\u003e\n\u003cp\u003eThe preview shown here is the exact document you’ll receive after purchase—fully formatted and ready to use. It presents a concise PESTLE analysis of GreeneStone Healthcare Corp., covering Political, Economic, Social, Technological, Legal, and Environmental factors relevant to strategy and risk assessment.\u003c\/p\u003e\n\u003cp\u003eNo placeholders, no teasers—this is the real, ready-to-use file you’ll get upon purchase, including actionable insights and implications for investors and managers. The layout, content, and structure visible here are exactly what you’ll download immediately after buying.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56751339307385,"sku":"greenestoneclinic-pestle-analysis","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/greenestoneclinic-pestle-analysis.png?v=1772230385","url":"https:\/\/growthsharematrix.com\/products\/greenestoneclinic-pestle-analysis","provider":"Growth Share Matrix","version":"1.0","type":"link"}